ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,836.66
      -0.11%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Immix Biopharma Inc (IMMX)

      7. Immix Biopharma Inc (IMMX) Financials

      Immix Biopharma Inc

      Immix Biopharma Inc (IMMX)

      NASDAQ
      2.24
      0.09
      (4.19%)
      Closed July 26 4:00PM
      Delayed by 15 minutes
      2.25
      0.01
      (0.45%)
      After Hours: 7:49PM
      Delayed by 15 minutes

      Immix Biopharma Inc Financial Summary

      The current IMMX market cap is 59.43M. The company's latest EPS is USD -0.5840 and P/E is -3.84.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -2.52M-3.72M-4.52M-5.38M-5.59M
      Net Income -2.48M-3.58M-4.28M-5.09M-5.26M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -842k-454k-1.35M-8.22M-16.14M
      Net Income -973k-1.15M-24.38M-8.23M-15.43M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 13.21M15.57M22.48M19.93M34.35M
      Total Liabilities 1.47M2.4M2.83M3.72M6.72M
      Total Equity 11.74M13.17M19.65M16.2M27.63M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 943k540k18.19M14.91M19.93M
      Total Liabilities 4.59M5.27M202k1.75M3.72M
      Total Equity -3.65M-4.73M17.99M13.16M16.2M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -2.09M-5.61M-8.69M-11.37M-3.83M
      Investing N/A N/A -39k-52k-302k
      Financing 119k4.81M14.88M15.46M15.95M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -790k-405k-1.59M-7.41M-11.37M
      Investing -7k N/A -1,000 N/A -52k
      Financing 1.05M N/A 18.85M3.23M15.46M

      Stats and Ratios

      Market Cap 59.43M
      Price to Earnings Ratio -3.84
      Price to Sales Ratio 0
      Price to Cash Ratio 3.38
      Price to Book Ratio 3.65
      Dividend Yield -

      Share Statistics

      Shares Outstanding 26.41M
      Average Volume (1 week) 72.66k
      Average Volume (1 Month) 172.81k
      52 Week Change 9.76%
      52 Week High 7.75
      52 Week Low 1.55
      Spread (Intraday) 0.03 (1.32%)

      Company Info

      Company Name Immix Biopharma Inc
      Address 3500 s dupont hwy
      dover, delaware 19901
      Website https://immixbio.com
      Industry pharmaceutical preparations (2834)